Eledon Pharmaceuticals, Inc. (ELDN) Corporate Subsidiaries
Eledon Pharmaceuticals, Inc. (ELDN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ELDN
CIK: 1404281
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerAmrita Nambiar
Audit LocationCosta Mesa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-8 | 2026-09-04 | — | S-8 | 0001193125-26-383824 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349314 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349170 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | 4 | 0001193125-26-333136 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | 4 | 0001193125-26-333133 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001370 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001193125-26-277653 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000921895-26-001390 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001193125-26-221702 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001193125-26-221658 | View SEC Doc Filr Page |
| EFFECT | 2026-05-11 | — | EFFECT Filing | 9999999995-26-001576 | View SEC Doc Filr Page |
| CORRESP | 2026-05-07 | — | CORRESP Filing | 0001193125-26-212858 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-07 | — | UPLOAD Filing | 0000000000-26-004691 | View SEC Doc Filr Page |
| S-3 | 2026-05-01 | — | S-3 | 0001193125-26-201426 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001193125-26-197775 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001193125-26-197765 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-18 | DEF 14A | 0001193125-26-197732 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-27 | — | SCHEDULE 13G Filing | 0002012383-26-001685 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-21 | 2026-06-18 | PRE 14A | 0001193125-26-164367 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-001125 | View SEC Doc Filr Page |
| 10-K | 2026-03-19 | 2025-12-31 | 10-K | 0001193125-26-116164 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-19 | 8-K | 0001193125-26-116154 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001346824-26-000041 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0001104659-26-015219 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-01-21 | — | SCHEDULE 13G/A Filing | 0002012383-26-000664 | View SEC Doc Filr Page |